PD-1 and PD-L1 as emerging therapeutic targets in gastric cancer: current evidence
about
Pembrolizumab for treatment of advanced gastric and gastroesophageal junction adenocarcinoma.Blockade of ITGA2 Induces Apoptosis and Inhibits Cell Migration in Gastric Cancer.Immunotherapy for Gastric Cancer: Time for a Personalized Approach?Molecular biomarkers in gastro-esophageal cancer: recent developments, current trends and future directions.Efficacy and safety of trastuzumab as maintenance or palliative therapy in advanced HER2-positive gastric cancerEmerging Therapies in the Management of Advanced-Stage Gastric CancerPrognostic significance of tumor immune microenvironment and immunotherapy: Novel insights and future perspectives in gastric cancer
P2860
Q47864236-99141C0D-E50F-4D41-B9DB-8F1ABCAF73F6Q55313144-A6DEF217-F441-4B86-B3DC-E2FB193746A5Q55652343-3ED832F6-6192-4E65-9290-23E8BAA834CAQ55654316-6D62BC89-E6FF-4260-B880-54E3143196B6Q57072196-18A9D78F-9140-4A67-95EE-3B6A55FF8479Q57111080-3AC81F27-2727-4B3F-98F3-09B01C95208FQ57167306-48CBC756-17A9-4124-9A02-3DD6131A9844
P2860
PD-1 and PD-L1 as emerging therapeutic targets in gastric cancer: current evidence
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
PD-1 and PD-L1 as emerging therapeutic targets in gastric cancer: current evidence
@en
type
label
PD-1 and PD-L1 as emerging therapeutic targets in gastric cancer: current evidence
@en
prefLabel
PD-1 and PD-L1 as emerging therapeutic targets in gastric cancer: current evidence
@en
P2093
P2860
P356
P1476
PD-1 and PD-L1 as emerging therapeutic targets in gastric cancer: current evidence
@en
P2093
Joseph Chao
Phu N Tran
Sarmen Sarkissian
P2860
P356
10.2147/GICTT.S113525
P577
2017-05-05T00:00:00Z